Table 2.
Clinical approach to renal adverse effects of ALK inhibitors
Adverse event | Mechanism | Management |
---|---|---|
Renal cyst | Unknown | Self-limiting, not to be confused with tumor progression |
Peripheral edema | Inhibition of c-MET | Diuretics only to be used if severe edema. Be mindful of electrolyte imbalances |
Elevated serum creatinine | Pseudo AKI, ATN | Check Cystatin Cbased glomerular filtration rate to rule out pseudo-AKI. If ATN, drug needs to be withheld |
Proteinuria | Likely podocytopathies | Consider holding or decreasing dose |